Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (121-130 of 186) with videos related to

Pageof 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infectionKatherine A Scilla, Dan P Zandberg, Søren M Bentzen, et al.
The Oncologist|May 24, 2017
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality TherapyKatherine A Scilla, Søren M Bentzen, Vincent K Lam, et al.
JAMA Network Open|August 14, 2023
Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer TreatmentZachary A K Frosch, Jill Hasler, Elizabeth Handorf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lungMartin J Edelman, Wael A Harb, Sridhar E Pal, et al.
Journal of Geriatric Oncology|June 1, 2018
Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622)Josephine L Feliciano, Jennifer G Le-Rademacher, Ajeet Gajra, et al.
ACS Medicinal Chemistry Letters|May 17, 2011
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring SystemAtul Kondaskar, Shilpi Kondaskar, Raj Kumar, et al.
Nature Communications|June 23, 2015
A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cellsYuping Mei, Yuyan Wang, Priti Kumari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2017
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance)Maria Q Baggstrom, Mark A Socinski, Xiaofei F Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2008
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)Richard J Gralla, Martin J Edelman, Frank C Detterbeck, et al.
The Annals of Thoracic Surgery|August 30, 2008
Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancerMartin J Edelman, Mohan Suntharalingam, Whitney Burrows, et al.
Pageof 19

Showing results (121-130 of 186) with videos related to

Sort By:
Pageof 19
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infectionKatherine A Scilla, Dan P Zandberg, Søren M Bentzen, et al.
The Oncologist|May 24, 2017
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality TherapyKatherine A Scilla, Søren M Bentzen, Vincent K Lam, et al.
JAMA Network Open|August 14, 2023
Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer TreatmentZachary A K Frosch, Jill Hasler, Elizabeth Handorf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lungMartin J Edelman, Wael A Harb, Sridhar E Pal, et al.
Journal of Geriatric Oncology|June 1, 2018
Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622)Josephine L Feliciano, Jennifer G Le-Rademacher, Ajeet Gajra, et al.
ACS Medicinal Chemistry Letters|May 17, 2011
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring SystemAtul Kondaskar, Shilpi Kondaskar, Raj Kumar, et al.
Nature Communications|June 23, 2015
A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cellsYuping Mei, Yuyan Wang, Priti Kumari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2017
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance)Maria Q Baggstrom, Mark A Socinski, Xiaofei F Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2008
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)Richard J Gralla, Martin J Edelman, Frank C Detterbeck, et al.
The Annals of Thoracic Surgery|August 30, 2008
Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancerMartin J Edelman, Mohan Suntharalingam, Whitney Burrows, et al.
Pageof 19